Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Measles and rubella]

D Gendrel1

  • 1Service de pédiatrie générale Hôpital Saint-Vincent-de-Paul, Paris.

La Revue Du Praticien
|October 27, 1997
PubMed
Summary
This summary is machine-generated.

Low measles-rubella vaccination coverage in France necessitates a booster dose at age eleven. This strategy aims to reduce disease incidence and prevent congenital rubella syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial treatment of diarrhea/acute gastroenteritis in children.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
Same author

Five-Day Spiramycin vs Seven-Day Penicillin V in the Treatment of Streptococcal Tonsillitis in Children.

Clinical drug investigation·2016
Same author

Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in France.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

[Safety of oral ivermectin in children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015
Same author

Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study".

Pathologie-biologie·2014
Same author

[Treatment of scabies: from recommendations to pediatric practice].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Context:

  • Measles and rubella pose ongoing public health risks due to suboptimal vaccination rates in France.
  • Low vaccination coverage (around 80%) allows for continued measles virus circulation and potential outbreaks, particularly in adolescents.
  • Rubella's asymptomatic nature in children facilitates transmission to non-immune pregnant women, risking congenital rubella syndrome.

Purpose:

  • To highlight the critical need for enhanced measles and rubella immunization strategies in France.
  • To advocate for the implementation of a universal vaccine booster dose at age eleven.
  • To underscore the public health benefits of reducing measles and rubella virus circulation.

Summary:

  • Measles presents with fever, rash, and conjunctivitis; vaccination significantly reduces complications and mortality.

Related Experiment Videos

  • Rubella infections are often asymptomatic in children but pose a severe risk to pregnant women, potentially causing congenital rubella syndrome.
  • Current vaccination coverage in France is insufficient to prevent measles outbreaks and congenital rubella syndrome.

    • Impact:

    • Implementing a booster dose at age eleven can decrease measles incidence and reduce the occurrence of congenital rubella syndrome.
    • Increased immunization coverage will protect vulnerable populations, including pregnant women and infants.
    • Strengthening vaccination programs is essential for controlling vaccine-preventable diseases.